ArticlePilot and feasibility studies2026
Pre-SAFEx: protocol for a single-centre, randomised, unblinded feasibility trial of Simultaneous Application of Flow at Extubation (SAFEx) in patients requiring intubation and ventilation for the management of acute respiratory failure.
Article in Pilot and feasibility studies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05904652 (A Randomised, Feasibility Trial of Simultaneous Application of Flow at Extubation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomised, Feasibility Trial of Simultaneous Application of Flow at Extubation (SAFEx) in Patients Requiring Intubation and Ventilation for the Management of Acute Respiratory Failure
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFailed extubation within critical care is associated with increased morbidity and mortality. Although the role of high-flow nasal therapy (HFNT) has been established post-extubation, it is not clear whether the delay in establishing HFNT after extubation adversely affects lung physiology, resulting in an increased risk of extubation failure. Early administration of HFNT may prevent lung derecruitment and reduce the rate of extubation failure. Electrical impedance tomography (EIT) is a non-invasive, non-ionising imaging method that allows continuous real-time measurement of lung physiology.
methodsThis is a single-centre, unblinded, randomised feasibility trial. Patients who have required intubation and ventilation for the management of acute respiratory failure will be recruited from the critical care unit at Queen Elizabeth University Hospital, Glasgow, Scotland. At the time of their planned extubation, patients will either be randomised to SAFEx extubation (where HFNT is established pre-extubation) or to standard care (where low-flow conventional oxygen therapy is established post-extubation). EIT will be used to compare the lung physiology of these two extubation strategies. DISCUSSION: This randomised feasibility trial will provide the relevant information to determine whether a multi-centre feasibility study comparing a SAFEx extubation against standard care is viable. It will also determine the feasibility of using EIT as a measure of changes in lung physiology peri-extubation. As extubation failure remains a significant burden for critical care services, with an associated lack of evidence addressing the impact that the oxygen delivery device has on the outcome of extubation in high-risk patients, this study aims to take the first step in addressing this important research question.
trial registrationClinicalTrials.Gov. REGISTRATION NUMBER: NCT05904652. Date of registration: 2023-06-15. https://clinicaltrials.gov/.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.